Trading Day Triumph: Bicara Therapeutics Inc (BCAX) Ends at 14.38, a -5.70 Surge/Plunge

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

Bicara Therapeutics Inc (NASDAQ: BCAX) closed the day trading at $14.38 down -5.70% from the previous closing price of $15.25. In other words, the price has decreased by -$5.70 from its previous closing price. On the day, 0.56 million shares were traded. BCAX stock price reached its highest trading level at $15.72 during the session, while it also had its lowest trading level at $14.13.

Ratios:

For a better understanding of BCAX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 36.01 and its Current Ratio is at 36.01. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 06, 2024, initiated with a Buy rating and assigned the stock a target price of $42.

On November 05, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $48.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’24 when RA CAPITAL MANAGEMENT, L.P. bought 1,833,000 shares for $18.00 per share. The transaction valued at 32,994,000 led to the insider holds 4,303,418 shares of the business.

Flynn James E bought 70,000 shares of BCAX for $1,260,000 on Sep 17 ’24. The Possible Members of 10% Group now owns 897,587 shares after completing the transaction at $18.00 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAX now has a Market Capitalization of 782496320 and an Enterprise Value of 262098608.

Stock Price History:

Over the past 52 weeks, BCAX has reached a high of $28.09, while it has fallen to a 52-week low of $15.15. The 50-Day Moving Average of the stock is -27.12%, while the 200-Day Moving Average is calculated to be -31.94%.

Shares Statistics:

Over the past 3-months, BCAX traded about 428.63K shares per day on average, while over the past 10 days, BCAX traded about 343910 shares per day. A total of 54.41M shares are outstanding, with a floating share count of 32.54M. Insiders hold about 40.20% of the company’s shares, while institutions hold 45.40% stake in the company. Shares short for BCAX as of 1734048000 were 3028320 with a Short Ratio of 10.55, compared to 1731628800 on 2072645.

Most Popular